ŞSŞule Seçkin

Şule Seçkin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Şule Seçkin has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Can urinary exosomal lncRNAs HOTAIR and MALAT1 predict surgical need and outcomes in unilateral antenatal hydronephrosis?

    by Rifat Burak Ergül, Rifat Burak, Canan Küçükgergin, Ismail Selvi, A Fatih Aydın, A. Fatih, Şule Seçkin, M İrFan Dönmez, M. İrfan, Orhan Ziylan, et al.

    Purpose Antenatal hydronephrosis is the most common prenatal urinary tract abnormality, and some cases, mainly due to ureteropelvic junction obstruction, require surgery. Noninvasive biomarkers are needed to improve diagnosis and guide management. To evaluate urinary exosomal long non-coding RNAs, specifically MALAT1 and HOTAIR, as biomarkers for predicting surgical necessity in children with unilateral antenatal hydronephrosis, and to develop an AI-based predictive model. Methods This retrospective case-control study included 88 children (38 requiring pyeloplasty, 26 non-obstructive dilatation, 24 controls). Urinary exosomes were isolated, and lncRNA expression was quantified by RT-qPCR. Clinical variables included anteroposterior pelvic diameter and split renal function. Diagnostic performance was assessed by ROC analysis and logistic regression. A SVM model was developed integrating biomarker and clinical data, with 5-fold cross-validation and an interactive Shiny web application for clinical translation. Results Preoperative MALAT1 and HOTAIR levels were significantly elevated compared to non-obstructive dilatation and controls and decreased after surgery (p < 0.001). MALAT1 remained an independent predictor of surgical intervention (OR = 1.272, p < 0.001) in multivariate analysis, alongside APD and SRF. MALAT1 showed an AUC of 0.745 (cut-off: 9.06), and HOTAIR an AUC of 0.685 (cut-off: 11.76). The SVM model achieved 91.9% accuracy, 89.5% sensitivity, 95.8% specificity, and an AUC of 0.951. Conclusions Urinary exosomal MALAT1 and HOTAIR are promising noninvasive biomarker for predicting surgical need in pediatric ureteropelvic junction obstruction. Integration with clinical parameters in an SVM-based model enhances diagnostic precision, and the development of a freely accessible web application supports real-time individualized risk prediction.

  • Open Access

    ZEB1-AS1 and miR-200b-3p Expression in Non-Muscle-Invasive Bladder Cancer: Pathological Correlates

    by Enes Degirmenci, Oner Sanli, Murat Kaytaz, Canan Kucukgergin, Selcuk Erdem, Sule Seckin, Yasemin Ozluk, Faruk Ozcan

    Purpose: Long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) have emerged as important regulators of the epithelial–mesenchymal transition (EMT) and tumor progression. The present study evaluated the expression profiles of lncRNA ZEB1-AS1 and miR-200b-3p in non-muscle-invasive bladder cancer (NMIBC) tissues and investigated their associations with clinicopathological characteristics. Materials and Methods: Tumor tissues and matched adjacent normal bladder tissue were obtained from 50 patients with primary NMIBC who underwent transurethral resection of bladder tumors. Total RNA was extracted, and expression levels of ZEB1-AS1 and miR-200b-3p were measured using quantitative real-time polymerase chain reaction (qRT-PCR). Relative expression levels were calculated using the 2−ΔΔCT method. Associations between gene expression levels and clinicopathological parameters were analyzed using non-parametric statistical tests. Receiver operating characteristic (ROC) curve analysis was performed to evaluate diagnostic performance. Results: ZEB1-AS1 and miR-200b-3p demonstrated significantly increased expression in tumor tissues compared with adjacent normal bladder tissue (p = 0.018 and p = 0.034, respectively). ZEB1-AS1 expression was significantly higher in high-grade tumors (p = 0.007), whereas miR-200b-3p expression was more pronounced in low-grade tumors (p = 0.015). No significant associations were identified between expression levels and tumor stage, carcinoma in situ, or variant histology. ROC analysis demonstrated modest diagnostic performance, with AUC values of 0.637 for ZEB1-AS1 and 0.624 for miR-200b-3p. Conclusions: ZEB1-AS1 and miR-200b-3p demonstrated distinct expression patterns associated with tumor grade and may contribute to EMT-associated molecular heterogeneity in NMIBC. Although the individual diagnostic performance of these markers appeared limited, the present findings provide additional insight into non-coding RNA-associated pathways and support further investigation in larger validation studies.

  • Urinary HSP70 can predict the indication of surgery in unilateral ureteropelvic junction obstruction

    by Tayfun Oktar, Canan Küçükgergin, M. İrFan Dönmez, Ünsal Özkuvancı, Alev Yılmaz, Zeynep Yürük Yıldırım, Selçuk Erdem, Şule Seçkin, Orhan Ziylan

    Background Distinguishing hydronephrosis that requires surgical intervention is a clinical challenge. The aim of this study is to determine the level of urinary heat shock protein 70 (HSP70) in children who required surgery for ureteropelvic junction obstruction and its potential use as a biomarker for prediction of surgery in children with isolated unilateral hydronephrosis. Methods The data of 43 children with ureteropelvic junction obstruction who underwent pyeloplasty, 25 patients with non-obstructive dilation (NOD) and 30 healthy children (control group) were collected prospectively for this study. Preoperative and postoperative urinary HSP70/Cr levels were also analyzed in 30 children in the pyeloplasty group who had available follow-up information. HSP70 levels were assessed using ELISA. Results The median age of the pyeloplasty group was 13 months (IQR 7–36 months), NOD group was 42.5 months (IQR 16–73) and it was 36 months (IQR 24–47.5) in the control group. The mean preoperative urinary HSP70/Cr was significantly higher in the pyeloplasty group when compared to controls as well as the NOD group (150.6 pg/mgCr vs. 65.0 pg/mgCr and vs. 64.7 pg/mgCr, p < 0.001 and p < 0.001, respectively). The urinary HSP70 levels significantly decreased in the postoperative period (151.5 vs 79.5, p < 0.001). Using the cutoff value of 94.7 pg/mgCr, the sensitivity and specificity of urinary HSP70 for predicting the risk of surgical intervention were 69.7% and 68%, respectively (AUC = 0.689). Conclusion Urinary HSP70 may be used as an adjunct tool to clinical parameters to identify patients that would require surgery due to ureteropelvic junction obstruction.


  • Response to letter to the editor re ‘Can urinary biomarkers detect obstruction defined by renal functional loss in antenatal hydronephrosis?’

    by Ünsal Özkuvancı, M.I. Dönmez, Orhan Ziylan, Tayfun Oktar, Canan Küçükgergin, Bilal Çetin, Selçuk Erdem, Şule Seçkin

  • Can urinary biomarkers detect obstruction defined by renal functional loss in antenatal hydronephrosis?

    by Ünsal Özkuvancı, M. İrFan Dönmez, Orhan Ziylan, Tayfun Oktar, Canan Küçükgergin, Bilal Çetin, Selçuk Erdem, Şule Seçkin


  • Open Access

    Diagnostic utility of serum and pleural levels of adenosine deaminase 1–2, and interferon-γ in the diagnosis of pleural tuberculosis

    by Sibel Yurt, Canan Küçükergin, Burcu Arpinar Yigitbas, Şule Seçkin, Hüseyin Cem Tigin, Ayşe Filiz Koşar

    To evaluate and compare the diagnostic efficiency of serum (s) and pleural (p) levels of adenosine deaminase (ADA)-1, ADA-2, total ADA, and interferon-gamma (IFN-γ) for the differential diagnosis of pleural tuberculosis (TB).


  • Association between SDF1-3′A or CXCR4 gene polymorphisms with predisposition to and clinicopathological characteristics of prostate cancer with or without metastases

    by Ferruh K. İşman, Canan Kucukgergin, Selçuk Daşdemir, Bedia Cakmakoglu, Oner Sanli, Sule Seckin

    In the present study, we aimed to investigate the association between SDF1-3′A and CXCR4 gene polymorphisms and the susceptibility and clinicopathological development of prostate cancer. SDF1-3′A and CXCR4 gene polymorphisms were assessed by polymerase chain reaction restriction-fragment length polymorphism (PCR–RFLP) in 149 healthy subjects and 152 patients with prostate cancer. There were no significant differences in the distributions of SDF-1 and CXCR4 genotypes between controls and prostate cancer patients. However, the patients with AA genotype of SDF1-3′A gene presented a higher risk for developing an advanced disease status as compared to patients with GG homozygotes (aOR = 2.02; 95 % CI = 1.05-3.90; P = 0.035). In addition, the distribution of AA genotype of SDF1-3′A gene was found significantly increased in the patients with bone metastasis in comparison to those without bone metastasis (aOR = 2.94; 95 % CI = 1.26-6.82; P = 0.012). On the other hand, CXCR4 gene polymorphism was not associated with the clinicopathological characteristics of prostate cancer. Our results suggest that SDF1-3′A and CXCR4 gene polymorphisms may not be risk factors for the susceptibility to prostate cancer. However, SDF1-3′A gene polymorphism may be associated with the progression and bone metastasis of prostate cancer in a Turkish men population.


  • Association of Polymorphisms in MCP-1, CCR2, and CCR5 Genes with the Risk and Clinicopathological Characteristics of Prostate Cancer

    by Canan Kucukgergin, Ferruh K. Isman, Bedia Cakmakoglu, Oner Sanli, Sule Seckin

    The aim of our study was to determine the effect of monocyte chemotactic protein-1 (MCP-1), CC chemokine receptor 2 (CCR2), and CC chemokine receptor 5 (CCR5) gene polymorphisms on the susceptibility and clinicopathological characteristics of prostate cancer. Genotyping was performed by polymerase chain reaction (PCR)–restriction fragment length polymorphism (RFLP) method in 156 histopathologically confirmed prostate cancer patients and 152 healthy subjects. Individuals with AA genotype or at least one A allele of CCR2 V64I gene polymorphism had a higher risk for prostate cancer as compared with those with GG genotype (p=0.010 and p=0.028, respectively). CCR5 Δ32/wt genotype and CCR5 Δ32 allele were also found to be involved in the susceptibility to prostate cancer (p=0.028 and p=0.030, respectively). However, there was no significant association between MCP-1-2518 A/G gene polymorphism and prostate cancer risk. Prostate cancer patients carrying AA genotype or at least one A allele of CCR2 V64I had significantly increased risk for high stage disease (p=0.002 and p=0.039, respectively) and metastasis (p=0.004 and p=0.022, respectively). The CCR2 A allele (64I allele) was significantly associated with high T stage (p=0.001) and metastasis (p=0.005) as compared with CCR2 G allele (64V allele). Our data indicate that gene polymorphism of CCR2 V64I may influence the susceptibility and clinicopathological characteristics of prostate cancer and CCR5 Δ32 allele may also be an important risk factor for prostate cancer in Turkish men population.


  • Genetic variants of MnSOD and GPX1 and susceptibility to bladder cancer in a Turkish population

    by Canan Kucukgergin, Oner Sanli, Akın S. Amasyalı, Tzevat Tefik, Sule Seckin

    This study was conducted to investigate the association of genetic polymorphisms in the MnSOD and GPX1 genes with the risk and invasiveness of bladder cancer in a Turkish population. This prospectively designed study enrolled 157 patients with bladder cancer (mean age 63.2 ± 10.86 years) and 224 healthy controls (mean age 61.7 ± 8.39 years). Genotyping of the MnSOD Ala-9Val and GPX1 Pro198Leu polymorphisms was carried out by PCR–RFLP. No significant difference was found in MnSOD genotype distributions between the controls and the bladder cancer patients. However, the Leu/Leu genotype of GPX1 was associated with a significantly higher risk of bladder cancer than the Pro/Pro genotype. When stratified according to tumor stage, the Leu/Leu genotype of GPX1 was more frequently observed in bladder cancer patients with high-stage tumors than those with low-stage tumors. Additionally, patients carrying both Ala/Ala of MnSOD and Leu/Leu of GPX1 had the highest risk of developing bladder cancer. In conclusion, the present study indicates that the GPX1 Pro198Leu polymorphism may be associated with the risk and development of invasive bladder cancer. In addition, the combination of the MnSOD Ala/Ala and GPX1 Leu/Leu genotypes may have a synergistic effect on disease risk.